Eterus Capital has acquired a minority stake in GroupSolver INC
Eterus Capital has acquired a minority stake in GroupSolver INC.
Eterus Capital is a Slovak private equity fund which has been helping Slovak companies grow since 2008.
GroupSolver is a market research technology company based in San Diego, with operations in Utah in the US and Slovakia. It has built an intelligent market research platform (think "online survey with a brain") that helps businesses answer their burning why, how, and what questions faster and with more confidence. By combining machine learning and crowd intelligence, the GroupSolver® technology helps decision-makers and researchers find insights that traditionally remain hidden from online surveys or focus groups.
Oaklins’ team in Slovakia advised Eterus Capital on this transaction.


Talk to the deal team
Related deals
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreSTM Environmental has been acquired by Phenna Group
STM Environmental has been acquired by Phenna Group, gaining access to a broader network of expertise, enhanced resources and global reach. With extensive experience in life safety, environmental compliance and quality testing, along with a wide client base, Phenna Group is the ideal partner to accelerate STM Environmental’s expansion.
Learn moreDimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn more